Table I. Cytokine/chemokine profile of poly(I:C)- or MHV-68–infected human trophoblast.
Factor | Poly(I:C) | MHV-68 |
---|---|---|
IL-6 | ↑6.3 | ↑3.3 |
IL-1B | — | ↑4.5 |
VEGF | — | ↑1.2 |
FGF-2 | ↑2.0 | ↑5.7 |
IL-8 | ↑7.2 | ↓11.5 |
MCP-1 | ↑1.7 | ↓162.5 |
RANTES | ↑2.3 | ↓2.4 |
GRO-α | ↑6.5 | ↓8.7 |
IL-1α | ↑115.8 | — |
GM-CSF | ↑261.1 | — |
IL-12p70 | ↑2.2 | ↓2.0 |
IFN-γ | ↑6.9 | ↓1.5 |
IP-10 | ↑225.2 | ↓3.3 |
IFN-α | ↑2.6 | ↓1.5 |
IFN-β | ↑60.0 | ↑3.0 |
Cytokine/chemokine profile of poly(I:C)-treated and MHV-68–infected human primary trophoblast. Isolated human first trimester trophoblast cells were treated with either 25 μg/ml poly(I:C) or MHV-68 at a multiplicity of infection of 1.4 for 72 h. Supernatants were collected, and cytokines and chemokines were measured by Multiplex. Fold changes (mean ± SEM) of cytokine/chemokine secretions with poly (I:C) and MHV-68. n = 3 samples per group. *p < 0.05.
↓ Decrease; ↑, increase; FGF-2, fibroblast growth factor-2; GRO-α, growth-related oncogene-α; IP-10, IFN-γ–inducible protein-10.